A specialized distributor of cannabis-based medicines and API’s

Improving international access to EU-GMP certified products for the pharmaceutical industry.


We take pride in our partnerships and take the time to monitor and audit our suppliers, in order to guarantee quality throughout the supply chain


With the help of our advisors, we take the time to understand patient’s needs and guide our commercial strategy accordingly


Our network of suppliers in Portugal, Colombia and Canada allows us to navigate the diverse regulatory requirements of an international client base


Cannaport aims to solve the fundamental issues the industry is facing – lack of qualified products, quality and difficulty meeting regulatory standards.

Our goal is to ensure our clients can access any medicinal cannabis product their patients require, with their own brand. Simultaneously, we help suppliers grow – facilitating their access to new clients and markets.

Cannaport is present in Europe, North and South America.


Guilherme Félix da Costa


Guilherme previously worked at the pharmaceutical multinational Reckitt-Benckiser’s global office in the UK, and has owned several of his own businesses. He holds a BSc in Business Management, University of Gloucestershire.

Diogo Mendes


Diogo has a background in Finance and Private Equity with a focus on agribusiness and infrastructure. He possesses a MSc in Finance from Cass Business School, University of London and BSc in Business Management from Royal Holloway University of London.

José Pedro Sequeira

Pharmaceutical Technical Director

Graduated in Pharmaceutical Sciences from the University of Coimbra, Pedro has vast experience in Pharmaco-vigilance and Clinical Trials monitoring, having worked at Infarmed I.P., and a pharmaceutical distributor where he assumed the role of technical director. Currently works at the European Medicines Agency.


Cannaport’s advisors provide great insight into patients and the market’s needs, and aid in driving the company in the right direction

Dr. Artur Aguiar

Doctor of Radio-Oncology at the Portuguese Institute of Oncology (IPO) in Porto since 2015. He specializes in the treatment of chronic pain at a dedicated unit of the same institution, and has a postgraduate degree in Pain Medicine from the Faculty of Medicine, University of Porto. He is a member of the scientific board of the Portuguese Observatory of Medicinal Cannabis (OPCM) since its start.


We focus on the sale of white-label final products and on the wholesale of raw materials, such as flower, extracts, destillates and isolates

Dry Cannabis Flower

GACP and GMP Certified

Bulk Oils & Derivatives

Pharma (GMP) and API Grade


With a strategic position in the market, Cannaport also offers consulting and brokerage services B2B to help your business grow


We help you develop your business through our deep expertise – in the field and in the market


We help clients meet their product needs through our partners, and likewise help our partners grow

Contact Us